Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Study of Rosiglitazone in Patients With Incurable Differentiated Thyroid Cancer

NCT00098852 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT00098852
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00098852 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Study of Rosiglitazone in Patients With Incurable Differentiated Thyroid Cancer
Lead sponsor
University of California, San Francisco
Phase
Phase 2
Overall status
Unknown status
Start date
October 31, 2004
Completion date
Not reported
Enrollment
25 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

head and neck cancer